PMID: 3753892Apr 1, 1986Paper

Hypothalamic-pituitary function of children with acute lymphocytic leukemia after three forms of central nervous system prophylaxis. A retrospective study

Cancer
M L VoorhessA Freeman

Abstract

The hypothalamic-pituitary function of 93 children, who had received central nervous system (CNS) prophylaxis as part of their therapy for acute lymphocytic leukemia (ALL), and who remained in continuous complete remission, was evaluated retrospectively. Treatment regimens included--Group I: 31 subjects, intrathecal methotrexate (IT MTX); Group II: 31 subjects, IT MTX plus 2400 rad cranial irradiation; and Group III: 31 subjects, IT MTX and intravenous intermediate-dose methotrexate. Serum thyroid-stimulating hormone (TSH) and T4 levels were normal. All participants had normal adrenocorticotropic hormone (ACTH) secretion as assessed by plasma cortisol responses to insulin hypoglycemia. Urinary follicle-stimulating hormone (FSH) and luteinizing hormone (LH) excretion of pubertal and postpubertal patients (N = 37) was appropriate, except for one subject from Group I who had an abnormally high output of gonadotropins, and one from Group II who had abnormally low levels. Growth hormone (GH) responses were subnormal after sequential arginine-insulin stimulation as follows--Group 1: 3 of 31 patients; Group II: 6 of 25 patients; and Group III: 2 of 29 patients. Nevertheless, all children had normal linear growth. It was concluded that...Continue Reading

References

Jun 1, 1977·The Journal of Pediatrics·S M ShaletD Pearson
Apr 1, 1977·The Journal of Clinical Endocrinology and Metabolism·R PennyS D Frasier
Dec 1, 1976·The Journal of Clinical Endocrinology and Metabolism·R PennyD Frasier
May 1, 1975·The Journal of Clinical Endocrinology and Metabolism·H E KulinA J Ferber
Nov 1, 1969·The Journal of Clinical Endocrinology and Metabolism·R PennyW T Davis

❮ Previous
Next ❯

Citations

Jan 1, 1994·International Journal of Clinical & Laboratory Research·L PaganoG Leone
Aug 30, 2000·Medical Oncology·S M Blaney, D G Poplack
Mar 2, 2006·Pituitary·Ken H Darzy, Stephen M Shalet
Aug 1, 1995·Critical Reviews in Oncology/hematology·S L Berg, D G Poplack
Aug 1, 1991·Acta Paediatrica Japonica; Overseas Edition·I Tsukimoto
Sep 1, 1995·Acta Paediatrica. Supplement·A Leiper
Apr 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel M GreenLeslie L Robison
Apr 16, 2015·The Lancet. Diabetes & Endocrinology·Elizabeth CrowneAndrew Toogood
Jun 29, 2010·Pediatric Blood & Cancer·Alix E SeifSusan R Rheingold
Jan 1, 1987·Medical and Pediatric Oncology·R J PackerG D'Angio
Jul 1, 1997·The Journal of Pediatrics·J RomanL Sierrasesúmaga
Jan 1, 1988·Pediatric Hematology and Oncology·R NygaardF Wesenberg
Jan 1, 1988·Pediatric Hematology and Oncology·M G ZurloA Mancini
Jul 1, 1991·Pediatric Hematology and Oncology·S P DibenedettoM Caruso-Nicoletti
Dec 1, 1991·Archives of Disease in Childhood·M UruenaA D Leiper
Apr 1, 1997·Journal of Endocrinological Investigation·A MohnF Angrilli
Oct 31, 2019·The Journal of Clinical Endocrinology and Metabolism·Khyatisha SeejoreRobert D Murray
Dec 26, 2019·BMC Bioinformatics·Jianwei LuTianwei Yu
Aug 3, 2019·The Journal of Clinical Endocrinology and Metabolism·Laura van IerselWassim Chemaitilly

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.